Automated Stem Cell Culture System Reducing Variability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for maintaining and differentiating human pluripotent stem cells, particularly induced pluripotent stem cells (iPSCs), are labor-intensive and prone to inter-technician variability, limiting large-scale studies and high-throughput analysis.

Innovation Solution

An automated system utilizing a customized Freedom EVO platform with a manipulator arm, liquid handling system, and disposable tip carrier for sterile cell culture, passaging, and differentiation, enabling controlled and programmed dispensing and removal of solutions to minimize variability and increase sample size.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If manual methods are used for maintaining and differentiating human pluripotent stem cells, then flexibility and adaptability are maintained, but labor intensity increases and inter-technician variability is introduced

Engineering Contradiction:
Improvereduction of inter-technician variabilityVSAvoidautomation of cell culture processes
Core Design Contradiction:
ReliabilityVSExtent of automation

Solution Approach 1:

The automated liquid handling system performs cell culture operations autonomously without requiring continuous human intervention. The system self-manages medium dispensing, cell passaging, and differentiation processes, thereby eliminating inter-technician variability while maintaining process reliability through programmed protocols

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

Manual mechanical operations (pipetting, medium changes, cell handling) are replaced by an automated liquid handling system with robotic arms and programmable dispensers. This substitution eliminates human variability introduced during manual operations while maintaining the necessary flexibility through software-controlled protocols

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Productivity

If manual cell culture methods are used, then process flexibility is maintained, but sample size and throughput are limited

Engineering Contradiction:
Improvesample size and throughputVSAvoidtime required for cell maintenance
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The automated system enables continuous cell culture operations without interruption by manually performing tasks. Multiple plates can be processed in sequence or parallel, with the system continuously dispensing medium, monitoring cells, and performing passaging operations, thereby increasing throughput and reducing total processing time

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

Culture protocols and differentiation procedures are pre-programmed into the automated system before experiments begin. This preliminary configuration allows the system to execute multiple samples simultaneously without requiring real-time human decision-making, thereby increasing sample size capacity and reducing overall processing time

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If automated liquid handling is implemented, then precision and control are improved, but system complexity increases

Engineering Contradiction:
Improveprecision of solution dispensingVSAvoidcomplexity of automated system
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The automated liquid handling system provides precise control over dispensing parameters (volume, speed, timing) through programmable parameters. By adjusting these parameters, the system achieves high precision in solution dispensing while managing system complexity through software-based parameter optimization rather than hardware complexity

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS11149245B2Automated system for maintenance and differentiation of pluripotent stem cells
Publication Date: 2021.10.19 TECAN TRADING AG
  • US11149245B2 patent drawing
  • US11149245B2 patent drawing
  • US11149245B2 patent drawing

AI summary

The present invention relates to the automated maintenance of cells particularly reprogrammed somatic cells into iPSCs to enable the large-scale culture and passaging of human pluripotent stem cells (PSCs) that can be adapted to a Freedom EVO®.